Respiratory

Respiratory drug development is inherently complex and demands a highly focused clinical strategy. An experienced Contract Research Organization (CRO) plays a critical role in navigating the unique operational and scientific challenges of respiratory clinical trials across all phases and diverse investigational products, including biologic therapies.

OUR EARLY PHASE
EXPERIENCE
THAT MATTERS

50+

Studies

1800+

Subjects

Proven experience with a wide range of drug molecules

  • Alcaftadine
  • Epinephrine
  • Azelastine Hydrochloride and Fluticasone Propionate
  • Methylcobalamin
  • Nalmefene
  • Tiotropium
  • Albuterol
  • Budesonide and Formoterol Fumarate
  • Fluticasone Furoate and Vilanterol
  • Fluticasone
  • Indacaterol and Glycopyrronium
  • Ipratropium
  • Mometasone Furoate
  • Olopatadine
  • Salbutamol
2 GCP/GLP Compliant laboratories- Ahmedabad, India and Toronto, Canada
State-of-the-art infrastructure – LCMS/MS, ICP-MS, MSD/ECL platforms and more
950+

Validated assays

50+

New Methods Evaluated Every Year

1.2+

Million Sample Analysis Capacity

Explore our Bioanalytical Laboratory Services

OUR LATE PHASE
EXPERIENCE
THAT MATTERS

20+

Studies

2000+

Sites

5000+

Patients

Top Indications

ENABLING BETTER BREATHING THROUGH RESEARCH — CONTACT US.

Research delivered with Integrity

CONTACT US
Cliantha Research Logo

Privacy Policy

Cookie Policy

© 2026 All Rights Reserved Cliantha Research.